Rutgers University is a clinical trial site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s COVID-19 vaccine candidate. Rutgers will enroll as many as 2,000...
Researchers tested nearly 4,000 employees and clinicians at Robert Wood Johnson University Hospital in New Brunswick, NJ, between April 28 and June 30, following a COVID-19 surge in the Garden State that began in March. Of those tested, 13 employees had COVID-19, and...
The Rutgers Institute for Health, Health Care Policy and Aging Research has received $10 million in funding from the Robert Wood Johnson Foundation and Rutgers University to support the New Jersey Population Health Cohort Study – the largest study to date to explore...
Rutgers Biomedical and Health Sciences leaders Brian Strom, Vicente Gracias, Mary O’Dowd and Frank Ghinassi offer an update on the pandemic and efforts to keep the community safe and well. To view the round table discussion.
